60 Degrees Pharmaceuticals, Inc., a Delaware corporation, was founded on June 1, 2022. The company is a specialty pharmaceutical company with the goal of leveraging cutting-edge biological science and applied research to further develop and commercialize new therapies for the prevention and treatment of infectious diseases. The company has successfully won regulatory approval for Arakoda, a malaria preventive treatment that has been on the market since late 2019. Currently, 60P's pipeline of research and development covers vector-borne, fungal and viral diseases utilizing the company's three future products.
